Published in Curr Opin Clin Nutr Metab Care on January 01, 2013
Publication trends in cachexia and sarcopenia in elderly heart failure patients. Wien Klin Wochenschr (2016) 0.78
Discerning primary and secondary factors responsible for clinical fatigue in multisystem diseases. Biology (Basel) (2014) 0.77
New Approaches to Treating Cardiac Cachexia in the Older Patient. Curr Cardiovasc Risk Rep (2013) 0.76
Mitochondrial co-chaperone protein Tid1 is required for energy homeostasis during skeletal myogenesis. Stem Cell Res Ther (2016) 0.75
Control of stress-dependent cardiac growth and gene expression by a microRNA. Science (2007) 12.08
Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J (2010) 5.04
MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest (2009) 4.39
Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation (2005) 3.86
Smad2 and 3 transcription factors control muscle mass in adulthood. Am J Physiol Cell Physiol (2009) 2.75
Myostatin activation in patients with advanced heart failure and after mechanical unloading. Eur J Heart Fail (2010) 2.40
Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol (2003) 2.35
A cardiac microRNA governs systemic energy homeostasis by regulation of MED13. Cell (2012) 2.29
Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J Clin Invest (2005) 2.24
Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure. Circulation (2010) 2.23
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet (2003) 2.10
Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2. EMBO J (2007) 1.61
Chronic heart failure reduces Akt phosphorylation in human skeletal muscle: relationship to muscle size and function. J Appl Physiol (1985) (2010) 1.59
The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy. EMBO J (2008) 1.59
S6 kinase inactivation impairs growth and translational target phosphorylation in muscle cells maintaining proper regulation of protein turnover. Am J Physiol Cell Physiol (2007) 1.44
Impaired muscle protein anabolic response to insulin and amino acids in heart failure patients: relationship with markers of immune activation. Clin Sci (Lond) (2010) 1.44
Limited maximal exercise capacity in patients with chronic heart failure: partitioning the contributors. J Am Coll Cardiol (2010) 1.38
The role of myostatin in muscle wasting: an overview. J Cachexia Sarcopenia Muscle (2011) 1.36
Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt. Am J Physiol Cell Physiol (2009) 1.35
Coordinated changes in mitochondrial function and biogenesis in healthy and diseased human skeletal muscle. FASEB J (2005) 1.27
Diaphragm single-fiber weakness and loss of myosin in congestive heart failure rats. Am J Physiol Heart Circ Physiol (2007) 1.20
Proteasome inhibition improves diaphragm function in congestive heart failure rats. Am J Physiol Lung Cell Mol Physiol (2008) 1.19
Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms. Cardiovasc Res (2009) 1.18
Impact of exercise training on myostatin expression in the myocardium and skeletal muscle in a chronic heart failure model. Eur J Heart Fail (2009) 1.14
Mechanisms underlying skeletal muscle weakness in human heart failure: alterations in single fiber myosin protein content and function. Circ Heart Fail (2009) 1.13
Reduced knee extensor function in heart failure is not explained by inactivity. Int J Cardiol (2009) 1.13
Immune activation is associated with reduced skeletal muscle mass and physical function in chronic heart failure. Int J Cardiol (2005) 1.08
Interleukin-6 markedly decreases skeletal muscle protein turnover and increases nonmuscle amino acid utilization in healthy individuals. J Clin Endocrinol Metab (2008) 1.04
Skeletal muscle myofibrillar protein metabolism in heart failure: relationship to immune activation and functional capacity. Am J Physiol Endocrinol Metab (2004) 1.03
Angiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus. Endocrinology (2012) 1.03
Inactivity amplifies the catabolic response of skeletal muscle to cortisol. J Clin Endocrinol Metab (1999) 1.02
Myostatin promotes the wasting of human myoblast cultures through promoting ubiquitin-proteasome pathway-mediated loss of sarcomeric proteins. Am J Physiol Cell Physiol (2011) 1.01
Skeletal muscle atrophy and peak oxygen consumption in heart failure. Am J Cardiol (1997) 0.99
Skeletal muscle and whole body protein turnover in cardiac cachexia: influence of branched-chain amino acid administration. Eur J Clin Invest (1988) 0.95
Increased plasma myostatin in heart failure. Eur J Heart Fail (2011) 0.95
Acute energy deprivation affects skeletal muscle protein synthesis and associated intracellular signaling proteins in physically active adults. J Nutr (2010) 0.95
Acute moderate elevation of TNF-alpha does not affect systemic and skeletal muscle protein turnover in healthy humans. J Clin Endocrinol Metab (2008) 0.93
Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure. J Intern Med (2006) 0.93
Exercise training leads to a reduction of elevated myostatin levels in patients with chronic heart failure. Eur J Prev Cardiol (2011) 0.93
Intrinsic skeletal muscle alterations in chronic heart failure patients: a disease-specific myopathy or a result of deconditioning? Heart Fail Rev (2012) 0.92
Growth hormone resistance in severe heart failure resolves after cardiac transplantation. Eur J Heart Fail (2009) 0.92
Prevalence of malnutrition in hospitalized medical patients: impact of underlying disease. Dig Dis (2003) 0.92
Heart failure: a model of cardiac and skeletal muscle energetic failure. Pflugers Arch (2006) 0.90
Skeletal muscle myofibrillar protein oxidation and exercise capacity in heart failure. Basic Res Cardiol (2007) 0.87
Cytokines: muscle protein and amino acid metabolism. Curr Opin Clin Nutr Metab Care (2012) 0.86
Pathophysiology of fluid retention in heart failure. Contrib Nephrol (2010) 0.83
Differential phosphorylation of translation initiation regulators 4EBP1, S6k1, and Erk 1/2 following inhibition of alcohol metabolism in mouse heart. Cardiovasc Toxicol (2008) 0.81
Myostatin and muscle fiber size. Focus on "Smad2 and 3 transcription factors control muscle mass in adulthood" and "Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size". Am J Physiol Cell Physiol (2009) 0.81
Skeletal muscle endurance and muscle metabolism in patients with chronic heart failure. Can J Cardiol (2006) 0.80
Preserved muscle protein metabolism in obese patients with chronic heart failure. Int J Cardiol (2011) 0.77
Protein kinetics in stable heart failure patients. J Appl Physiol (1985) (2002) 0.76
Increased skeletal muscle amino acid release with light exercise in deconditioned patients with heart failure. J Am Coll Cardiol (2005) 0.76
The effect of weight loss and exercise training on flow-mediated dilatation in coronary heart disease: a randomized trial. Chest (2011) 2.15
High-calorie-expenditure exercise: a new approach to cardiac rehabilitation for overweight coronary patients. Circulation (2009) 2.08
A re-examination of the metabolic equivalent concept in individuals with coronary heart disease. J Cardiopulm Rehabil Prev (2007) 1.54
Correlation of serum androgens with anthropometric and metabolic indices in healthy, nonobese postmenopausal women. J Clin Endocrinol Metab (2010) 1.46
Deconvolution of mixture spectra from ion-trap data-independent-acquisition tandem mass spectrometry. Anal Chem (2010) 1.43
Chronic heart failure decreases cross-bridge kinetics in single skeletal muscle fibres from humans. J Physiol (2010) 1.17
Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. Fertil Steril (2002) 1.15
The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab (2005) 1.15
Mechanisms underlying skeletal muscle weakness in human heart failure: alterations in single fiber myosin protein content and function. Circ Heart Fail (2009) 1.13
Age-related slowing of myosin actin cross-bridge kinetics is sex specific and predicts decrements in whole skeletal muscle performance in humans. J Appl Physiol (1985) (2013) 0.98
Effect of a daily supplement of soy protein on body composition and insulin secretion in postmenopausal women. Fertil Steril (2007) 0.97
Effect of resistance training on physical disability in chronic heart failure. Med Sci Sports Exerc (2011) 0.96
Myofilament protein alterations promote physical disability in aging and disease. Exerc Sport Sci Rev (2013) 0.94
Ovarian suppression with a gonadotropin-releasing hormone agonist does not alter insulin-stimulated glucose disposal. Fertil Steril (2007) 0.90
Determination of steady-state protein breakdown rate in vivo by the disappearance of protein-bound tracer-labeled amino acids: a method applicable in humans. Am J Physiol Endocrinol Metab (2013) 0.89
Effect of ovariectomy and estradiol replacement on skeletal muscle enzyme activity in female rats. Metabolism (2002) 0.86
Progesterone stimulates cardiac muscle protein synthesis via receptor-dependent pathway. Fertil Steril (2004) 0.85
Insulin resistance with hormone replacement therapy: associations with markers of inflammation and adiposity. Am J Obstet Gynecol (2007) 0.84
Skeletal muscle contractile protein function is preserved in human heart failure. J Appl Physiol (1985) (2008) 0.84
Evidence against a role for ovarian hormones in the regulation of blood flow. Fertil Steril (2006) 0.83
Genes overexpressed in cerebral arteries following salt-induced hypertensive disease are regulated by angiotensin II, JunB, and CREB. Am J Physiol Heart Circ Physiol (2007) 0.82
Effect of heart failure on the regulation of skeletal muscle protein synthesis, breakdown, and apoptosis. Am J Physiol Endocrinol Metab (2003) 0.82
Cancer cachexia update in head and neck cancer: Definitions and diagnostic features. Head Neck (2014) 0.81
Effect of exercise training and weight loss on platelet reactivity in overweight patients with coronary artery disease. J Cardiopulm Rehabil Prev (2013) 0.80
An inverse power-law distribution of molecular bond lifetimes predicts fractional derivative viscoelasticity in biological tissue. Biophys J (2013) 0.79
Accelerated decline of aerobic fitness with healthy aging: what is the good news? Circulation (2005) 0.79
Effects of testosterone on cardiomyocyte calcium homeostasis and contractile function in female rats. Exp Physiol (2012) 0.76
Relationship of androgens to body composition, energy and substrate metabolism and aerobic capacity in healthy, young women. Steroids (2011) 0.75
Skeletal muscle adaptations to cancer and its treatment: their fundamental basis and contribution to functional disability. Crit Rev Eukaryot Gene Expr (2013) 0.75
Sex-specific Molecular And Cellular Functional Adaptations To Resistance Training In Inactive Older Adults: 1448 Board #101 June 2, 8: 00 AM - 9: 30 AM. Med Sci Sports Exerc (2016) 0.75